| Rosa F. Hwang, M.D., F.A.C.S. |
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education | |
| 1993 | University of Maryland at Baltimore, Baltimore, MD, MD, Medicine |
| 1989 | University of Maryland, College Park, MD, BS, Zoology and Psychology |
Postgraduate Training | |
| 3/2001-9/2002 | Research Fellowship, Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, Dr. Isaiah J. Fidler |
| 7/2000-6/2003 | Fellowship, Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, Dr. Raphael Pollock |
| 7/1995-6/1997 | Research Fellow, Gene Therapy Laboratories, The University of Southern California-Keck School of Medicine, Los Angeles, CA, Dr. W. French Anderson |
| 6/1993-6/2000 | Resident, General Surgery, The University of Southern California-Keck School of Medicine, Los Angeles, CA, Dr. Tom DeMeester |
Board Certifications
| 11/2012 | American Board of Surgery |
Experience/Service
Academic Appointments
Assistant Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 8/2004-8/2010
Assistant Professor, Department of Surgical Oncology, Division of Surgery, University of California, San Diego, San Diego, CA, 8/2003-7/2004
Other Appointments/Responsibilities
Reviewer, Program Committee, Society for Surgery of the Alimentary Tract (SSAT) Annual Meeting, Washington, DC, 5/2007
Committee Member, American Society of Breast Surgeons Publications Committee, Columbia, MD, 2007-2009
Institutional Committee Activities
Chair, Breast Tissue Oversight Committee, 1/2012-12/2012
Alternate Member, Institutional Tissue Utilization Committee (iTUC), 2011-present
Committee Member, Computerized Provider Order Entry (CPOE) Steering Committee, 4/2010-present
Primary Member, Breast Tissue Oversight Committee, The University of Texas M. D. Anderson Cancer Center, 2010-2013
Committee Member, Breast Cancer Screening Guidelines Development Team, The University of Texas M. D. Anderson Cancer Center, 2009-present
Member, Biospecimen Repository Advisory Committee (BRAC) - Pancreas Bank, The University of Texas M. D. Anderson Cancer Center, 2008-present
Member, Clinical Research Committee (CRC), The University of Texas M. D. Anderson Cancer Center, 2008-2011
Voting Member, Clinical Effectiveness Committee, The University of Texas M. D. Anderson Cancer Center, 2007-2013
Organizing Committee Member, Breast Cancer Research Group Retreat, Triple Negative/Basal-Like Breast Cancers, The University of Texas M. D. Anderson Cancer Center, 2006
Director, Pancreas Satellite Tissue Bank, The University of Texas M. D. Anderson Cancer Center, 2005-present
Honors and Awards
| 2012 | ASCO Conquer Cancer Foundation Merit Award, ASCO Conquer Cancer Foundation Board of Directors and the Breast Cancer Symposium Program Committee (Awardee - Breast Fellow - Lisa Allen, M.D.; Supervising Faculty Rosa F. Hwang, M. D.) |
| 2011 | AACR Scholar-in-Training Award given to Sarah Gainer, M.D. Surgical Breast Fellow (faculty supervisor, RH Hwang, M.D.), AACR |
| 2011 | Certificate of Excellence, Laboratory Investigation Journal |
| 2008 | America's Top Oncologists, Consumer's Research Council of America |
| 2008 | Trainee Travel Award for Oral Abstract Presented at "The Chronic Pancreatitis to Pancreatic Cancer Continuum", American Pancreatic Association (Awardee-Armando Rivera, Ph.D.; Supervising Faculty-Rosa Hwang, M.D. |
| 2006-2010 | Career Development Award, The University of Texas M. D. Anderson Cancer Center Panceas SPORE Career Development Award (5P20 CA101936), Principal Investigator, The role of tumor-associated stroma in the regulation of pancreatic cancer progression, $50,000 ($50,000/year) |
| 2006-2009 | Career Development Award, Society for Surgery of the Alimentary Tract (SSAT), Principal, Investigator, Tumor-stromal interactions in the regulation of pancreatic cancer progression, $100,000 ($50,000/year) |
| 2006 | Awardee, American Association for Cancer Research Minority Scholar Award in Cancer Research, American Association of Cancer Research |
| 2006 | Teaching Award, The University of Texas M. D. Anderson Cancer Center for Biomedical Engineering |
| 2005 | Teaching Award, The University of Texas M. D. Anderson Cancer Center for Biomedical Engineering |
| 2002 | Awardee, Research Fellowship, Method in Clinical Cancer Research Workshop, American Association for Cancer Research/American Society for Clinical Oncology |
| 2001 | Awardee, Research Fellowship, Molecular Biology and Clinical Oncology Workshop, American Association for Cancer Research/American Society for Clinical Oncology |
| 1989 | Phi Sigma Honor Society |
Professional Memberships
| American Association for Cancer Research Tumor Microenvironment Working Group, 2008-present Member, 2001-present |
| American College of Surgeons Fellow, 2008-present Candidate Member, 2000-2008 |
| American College of Surgeons Oncology Group Member, 2006-present |
| American Pancreatic Association Member, 2005-present |
| American Society of Breast Disease, Dallas, TX Member, 2008-present |
| American Society of Clinical Oncology Member, 2003-present |
| Association for Academic Surgery Education Committee Member, 2011-2013 Member, 2003-present |
| Harris County Medical Society, Houston, TX Member, 2009-present |
| National Institutes of Health/National Cancer Institute (NIH/NCI), Washington, DC Member of the Working Group of The Cancer Genome Atlas-Pancreatic Cancer, 2012-present |
| Pancreas Club Planning Committee Member, 2011 Member, 2002-present |
| Phi Beta Kappa Member, 1989-present |
| Society for Surgery of the Alimentary Tract Reviewer, Program Committee, 2007 Member, 2006-present |
| Society of Graduate Surgeons of the Los Angeles County/University of Southern California Medical Center, Los Angeles, CA Member, 2000-present |
| Society of Surgical Oncology Member, 2000-present |
| South Texas Chapter of the American College of Surgeons, Houston, TX Member, 2008-2011 |
| Texas Medical Association, Austin, TX Member, 2009-present |
| The American Society of Breast Surgeons Publications Committee Member, 2009-present Member, 2007-present |
| The Association for Surgical Education, Springfield, IL Member, 2008-present |
| The Society of University Surgeons, Maitland, FL Member, 2011-present |
Selected Publications
Peer-Reviewed Original Research Articles | ||
| 1. | Ma Y, Hwang RF, Logsdon CD, Ullrich S. Dynamic mast cell-stromal cell interactions promote pancreatic cancer growth. Cancer Res. In Press. | |
| 2. | Goicoechea SM, Garcia-Mata R, Staub J, Valdivia A, Sharek L, McCulloch CAG, Hwang RF, Urrutia R, Yeh JJ, Otey CA. Palladin promotes invasion of pancreatic cancer cells by enhancing invadopodia formation in tumor-associated fibroblasts. Oncogene. In Press. | |
| 3. | Yi M, Kuerer HM, Mittendorf EA, Hwang RF, Caudle AS, Bedrosian I, Meric-Bernstam F, Wagner JL, Hunt KK. Impact of the American College of Surgeons Oncology Group Z0011 criteria applied to a contemporary patient population. J Am Coll Surg 216(1):105-13, 1/2013. e-Pub 11/2/2012. PMID: 23122536. | |
| 4. | Alvarado R, Yi M, Le-Petross H, Gilcrease M, Mittendorf EA, Bedrosian I, Hwang RF, Caudle AS, Babiera GV, Akins JS, Kuerer HM, Hunt KK. The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer. Ann Surg Oncol 19(10):3177-84, 10/2012. e-Pub 7/7/2012. PMID: 22772869. | |
| 5. | Hwang RF, Moore TT, Hattersley MM, Scarpitti M, Yang B, Devereaux E, Ramachandran V, Arumugam T, Ji B, Logsdon CD, Brown JL, Godin R. Inhibition of the hedgehog pathway targets the tumor-associated stroma in pancreatic cancer. Mol Cancer Res 10(9):1147-57, 9/2012. e-Pub 8/2/2012. PMID: 22859707. | |
| 6. | Kim MP, Truty MJ, Choi W, Kang Y, Chopin-Lally X, Gallick GE, Wang H, McConkey DJ, Hwang R, Logsdon C, Abbruzzesse J, Fleming JB. Molecular Profiling of Direct Xenograft Tumors Established from Human Pancreatic Adenocarcinoma After Neoadjuvant Therapy. Ann Surg Oncol 19 Suppl 3:395-403, 7/2012. e-Pub 6/24/2011. PMID: 21701930. | |
| 7. | Erkan M, Adler G, Apte MV, Bachem MG, Buchholz M, Detlefsen S, Esposito I, Friess H, Gress TM, Habisch HJ, Hwang RF, Jaster R, Kleeff J, Klöppel G, Kordes C, Logsdon CD, Masamune A, Michalski CW, Oh J, Phillips PA, Pinzani M, Reiser-Erkan C, Tsukamoto H, Wilson J. StellaTum: current consensus and discussion on pancreatic stellate cell research. Gut 61(2):172-8, 2/2012. e-Pub 11/24/2011. PMCID: PMC3245897. | |
| 8. | Mittendorf EA, Hunt KK, Boughey JC, Bassett R, Degnim AC, Harrell R, Yi M, Meric-Bernstam F, Ross MI, Babiera GV, Kuerer HM, Hwang RF. Incorporation of sentinel lymph node metastasis size into a nomogram predicting non-sentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node. Ann Surg 255(1):109-15, 1/2012. PMID: 22167004. | |
| 9. | Krantz SB, Shields MA, Dangi-Garimella S, Cheon EC, Barron MR, Hwang RF, Rao MS, Grippo PJ, Bentrem DJ, Munshi HG. MT1-MMP cooperates with KrasG12D to promote pancreatic fibrosis through increased TGF-{beta} signaling. Mol Cancer Res 9(10):1294-304, 10/2011. e-Pub 8/19/2011. PMCID: PMC3196812. | |
| 10. | Arumugam T, Brandt W, Ramachandran V, Moore TT, Wang H, May FE, Westley BR, Hwang RF, Logsdon CD. Trefoil factor 1 stimulates both pancreatic cancer and stellate cells and increases metastasis. Pancreas 40(6):815-22, 8/2011. PMID: 21747314. | |
| 11. | Sharma R, Bedrosian I, Lucci A, Hwang RF, Rourke LL, Qiao W, Buchholz TA, Kronowitz SJ, Krishnamurthy S, Babiera GV, Gonzalez-Angulo AM, Meric-Bernstam F, Mittendorf EA, Hunt KK, Kuerer HM. Present-Day Locoregional Control in Patients with T1 or T2 Breast Cancer with 0 and 1 to 3 Positive Lymph Nodes After Mastectomy Without Radiotherapy. Ann Surg Oncol 17(11):2899-908, 11/2010. e-Pub 5/5/2010. PMID: 20443145. | |
| 12. | Bose D, Tamm E, Liu J, Marcal L, Balachandran A, Bhosale P, Fleming JB, Lee JE, Evans DB, Hwang RF. Multidisciplinary management strategy for incidental cystic lesions of the pancreas. J Am Coll Surg 211(2):205-215, 8/2010. e-Pub 6/8/2010. PMID: 20670858. | |
| 13. | Goicoechea SM, Bednarski B, Stack C, Cowan DW, Volmar K, Thorne L, Cukierman E, Rustgi AK, Brentnall T, Hwang RF, McCulloch CA, Yeh JJ, Bentrem DJ, Hochwald SN, Hingorani SR, Kim HJ, Otey CA. Isoform-specific upregulation of palladin in human and murine pancreas tumors. PLoS One 5(4):e10347, 2010. e-Pub 4/26/2010. PMCID: PMC2859948. | |
| 14. | Krishnamurthy S, Meric-Bernstam F, Lucci A, Hwang RF, Kuerer HM, Babiera G, Ames FC, Feig BW, Ross MI, Singletary E, Hunt KK, Bedrosian I. A prospective study comparing touch imprint cytology, frozen section analysis and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer. Cancer 115(7):1555-1562, 4/1/2009. PMID: 19195040. | |
| 15. | Katz MH, Wang H, Fleming JB, Sun CC, Hwang RF, Wolff RA, Varadhachary G, Abbruzzese JL, Crane CH, Krishnan S, Vauthey JN, Abdalla EK, Lee JE, Pisters PW, Evans DB. Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol 16(4):836-847, 4/2009. e-Pub 2/5/2009. PMCID: PMC3066077. | |
| 16. | Yi M, Meric-Bernstam F, Middleton LP, Arun BK, Bedrosian I, Babiera GV, Hwang RF, Kuerer HM, Yang W, Hunt KK. Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy. Cancer 115(5):962-971, 3/1/2009. e-Pub 1/2009. PMID: 19172584. | |
| 17. | Ramachandran V, Arumugam T, Langley R, Hwang RF, Vivas-Mejia P, Sood AK, Lopez-Berestein G, Logsdon CD. The ADMR Receptor Mediates the Effects of Adrenomedullin on Pancreatic Cancer Cells and on Cells of the Tumor Microenvironment. PLoS One 4(10):e7502, 2009. e-Pub 10/22/2009. PMCID: PMC2760778. | |
| 18. | Liang JJ, Wang H, Rashid A, Tan TH, Hwang RF, Hamilton SR, Abbruzzese JL, Evans DB, Wang H. Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma. Clin Cancer Res 14(21):7043-7049, 11/1/2008. PMID: 18981001. | |
| 19. | Yi M, Meric-Bernstam F, Ross MI, Akins JS, Hwang RF, Lucci A, Kuerer HM, Babiera GV, Gilcrease MZ, Hunt KK. How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer? Cancer 113(1):30-37, 7/1/2008. e-Pub 5/2008. PMID: 18457326. | |
| 20. | Katz MH, Mortenson MM, Wang H, Hwang R, Tamm EP, Staerkel G, Lee JH, Evans DB, Fleming JB. Diagnosis and management of cystic neoplasms of the pancreas: an evidence-based approach. J Am Coll Surg 207(1):106-120, 7/2008. e-Pub 4/24/2008. PMID: 18589369. | |
| 21. | Yi M, Krishnamurthy S, Kuerer HM, Meric-Bernstam F, Bedrosian I, Ross MI, Ames FC, Lucci A, Hwang RF, Hunt KK. Role of primary tumor characteristics in predicting positive sentinel lymph nodes in ductal carcinoma in situ or microinvasive breast cancer. Am J Surg 196(1):81-87, 7/2008. e-Pub 4/23/2008. PMID: 18436181. | |
| 22. | Katz MH, Pisters PW, Evans DB, Sun CC, Lee JE, Fleming JB, Vauthey JN, Abdalla EK, Crane CH, Wolff RA, Varadhachary GR, Hwang RF. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg 206(5):833-846, 5/2008. e-Pub 3/17/2008. PMID: 18471707. | |
| 23. | Hwang RF, Wang H, Lara A, Gomez H, Chang T, Sieffert N, Moon Y, Ram S, Zimmerman S, Lee JH, Pisters PW, Tamm EP, Fleming JB, Abbruzzese JL, Evans DB. Development of an integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancer. Ann Surg Oncol 15(5):1356-1366, 5/2008. e-Pub 2/7/2008. PMID: 18256882. | |
| 24. | Khalifeh IM, Albarracin C, Diaz LK, Symmans FW, Edgerton ME, Hwang RF, Sneige N. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma. Am J Surg Pathol 32(4):544-552, 4/2008. e-Pub 1/2008. PMID: 18300793. | |
| 25. | Katz MH, Hwang R, Fleming JB, Evans DB. Tumor-node-metastasis staging of pancreatic adenocarcinoma. CA Cancer J Clin 58(2):111-125, Mar-Apr, 3/2008. e-Pub 2/13/2008. PMID: 18272835. | |
| 26. | Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD, Rivera A, Ji B, Evans DB, Logsdon CD. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. (Highlighted Article). Cancer Res 68(3):918-926, 2/2008. PMCID: PMC2519173. | |
| 27. | Ramachandran V, Arumugam T, Hwang RF, Greenson JK, Simeone DM, Logsdon CD. Adrenomedullin is expressed in pancreatic cancer and stimulates cell proliferation and invasion in an autocrine manner via the adrenomedullin receptor (ADMR). Cancer Res 67(6):2666-2675, 2007. PMID: 17363587. | |
| 28. | Barush AC, Wang H, Staerkel GA, Evans DB, Hwang RF, Krishnamurthy S. Immunocytochemical study of the expression of mesothelin in fine-needle aspiration biopsy specimens of pancreatic adenocarcinoma. Diagn Cytopathol 35(3):143-147, 2007. PMID: 17304533. | |
| 29. | Raut CP, Tseng JF, Sun CC, Cleary KR, Wang H, Wolff RA, Abbruzzese JF, Varadhachary G, Tamm EP, Crane CH, Gomez HF, Hwang RF, Vauthey JN, Abdalla EK, Lee JE, Pisters PWT, Evans DB. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg 246(1):52-60, 2007. PMCID: PMC1899216. | |
| 30. | Hwang RF, Gonzalez-Angulo AM, Yi M, Buchholz TA, Meric-Bernstam F, Kuerer HM, Babiera GV, Tereffe W, Liu DD, Hunt KK. Low local-regional failure rates in selected breast cancer patients with tumor-positive sentinel nodes who do not undergo completion axillary dissection. Cancer 110:723-730, 2007. PMID: 17587208. | |
| 31. | Rosenkranz KM, Bedrosian I, Feng L, Hunt KK, Hartman K, Lucci A, Meric-Bernstam F, Kuerer HM, Singletary ES, Hwang R, Feig B, Ross M, Ames F, Babiera GV. Breast cancer in the very elderly: treatment patterns and complications in a tertiary cancer center. Am J Surg 192(4):541-544, 2006. PMID: 16978971. | |
| 32. | Boughey JC, Ross MI, Babiera GV, Bedrosian I, Feig BW, Hwang RF, Kuerer HM, Hunt KK. Sentinel lymph node surgery in locally recurrent breast cancer. Clin Breast Cancer 7(3):248-253, 2006. PMID: 16942642. | |
| 33. | Lambert LA, Ayers GD, Hwang RF, Hunt KK, Ross MI, Kuerer HM, Singletary SE, Babiera GV, Ames FC, Feig B, Lucci A, Krishnamurthy S, Meric-Bernstam F. Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy. Ann Surg Oncol 13(3):310-320, 2006. e-Pub 2/2006. PMID: 16463073. | |
| 34. | Garmy-Susini B, Jin H, Zhu Y, Sung RJ, Hwang R, Varner J. Integrin alpha4beta1-VCAM-1-mediated adhesion between endothelial and mural cells is required for blood vessel maturation. J Clin Invest 115(6):1542-1551, 2005. e-Pub 5/2005. PMCID: PMC1088016. | |
| 35. | Hwang RF, Yokoi K, Bucana CD, Tsan R, Killion JJ, Evans DB, Fidler IJ. Inhibition of platelet-derived growth factor reception phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model. (Cover Article). Clin Cancer Res 9(17):6534-6544, 12/2003. PMID: 14695158. | |
| 36. | Solorzano CC, Hwang R, Baker CH, Bucana CD, Pisters PW, Evans DB, Killion JJ, Fidler IJ. Administration of optimal biological dose and schedule of interferon alpha combined with gemcitabine induces apoptosis in tumor-associated endothelial cells and reduces growth of human pancreatic carcinoma implanted orthotopically in nude mice. Clin Cancer Res 9(5):1858-1867, 5/2003. PMID: 12738744. | |
| 37. | Hwang RF, Krishnamurthy S, Hunt KK, Mirza N, Ames FC, Feig B, Kuerer HM, Singletary SE, Babiera G, Meric F, Akins JS, Neely J, Ross MI. Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol 10(3):248-254, 4/2003. PMID: 12679309. | |
| 38. | Hwang RF, Hunt KK. Experimental approaches to treatment of soft tissue sarcoma. Surg Oncol Clin N Am 12(2):499-521, 4/2003. PMID: 12916466. | |
| 39. | Hwang RF, Gordon EM, Anderson WF, Parekh D. Gene therapy for primary and metastatic pancreatic cancer with intraperitoneal retroviral vector bearing the wild-type p53 gene. Surgery 124(2):143-150; discussion 150-151, 8/1998. PMID: 9706132. | |
| 40. | Yang L, Hwang R, Chiang Y, Gordon EM, Anderson WF, Parekh D. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex thymidine kinase gene. Clin Cancer Res 4(3):731-741, 3/1998. PMID: 9533543. | |
| 41. | Yang L, Hwang R, Pandit L, Gordon EM, Anderson WF, Parekh D. Gene therapy of metastatic pancreas cancer with intraperitoneal injections of concentrated retroviral herpes simplex thymidine kinase vector supernatant and ganciclovir. Ann Surg 224(3):405-414; discussion 414-417, 9/1996. PMCID: PMC1235392. | |
Invited Articles | ||
| 1. | Hwang RF. Commentary on: A simple nomogram to evaluate the risk of nonsentinel node metastases in breast cancer patients with minimal sentinel node involvement. Breast Diseases: A Year Book Quarterly 23(3):260-261, 2012. | |
| 2. | Hwang RF. Commentary on: Axillary recurrence is low in patients with breast cancer who do not undergo completion axillary lymph node dissection for micrometastases in sentinel lymph nodes. Am Surg 76:1088-1091, 2010. Breast Diseases: A Year Book Quartelry 22(4):396-397, 2011. | |
| 3. | Hwang RF. Commentary on: Predictors to assess non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis. Breast Diseases: A Year Book Quarterly 20(4):417, 2010. | |
| 4. | Hwang RF. Commentary on: Validation of a nomogram to predict the risk of nonsentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy: validation of the MSKCC breast nomogram. Breast Diseases: A Yearbook Quarterly 21(1):58, 2010. | |
| 5. | Hwang RF. Commentary on: Nomogram for the predicting of having four or more involved nodes for sentinel lymph node-positive breast cancer. Breast Diseases: A Year Book Quarterly 20(1):68, 2009. | |
| 6. | Hwang R. Commentary on: Differences in sentinel lymph node pathology protocols lead to differences in surgical strategy in breast cancer patients. Ann Surg Oncol 2006; 13: 1466-1473. Breast Diseases: A Year Book Quarterly 18:382, 2007. | |
| 7. | Hwang RF. Commentary on: Evaluation of a breast cancer nomogram for prediction of nonsentinel lymph node positivity. Eur J Surg Oncol 31:958-964, 2005. Breast Diseases: A Year Book Quarterly 17:380-381, 2007. | |
| 8. | Hwang RF. Commentary on: The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast. Eur J Surg Oncol 32:502-506, 2006. Breast Diseases: A Year Book Quarterly 18:80, 2007. | |
| 9. | Hwang RF. Commentary on: The significance of one positive axillary node. Eur J Surg Oncol 32:139-142, 2006. Breast Diseases: A Year Book Quarterly 17:383-384, 2007. | |
| 10. | Hwang RF, Evans DB. CA19-9 and CA 125 markers in the differential diagnosis of pancreatic mass lesions. Arch Surg 141:974, 2006. | |
| 11. | Hwang RF. Commentary on: Primary tumor characteristics predict sentinel lymph node macrometastasis in breast cancer. Breast J 11:338-343, 2005. Breast Diseases: A Year Book Quarterly 17:174, 2006. | |
| 12. | Hwang RF. Commentary on: Ratio on positive to total number of sentinel nodes predicts nonsentinel node status in breast cancer patients. Breast J 11:248-253, 2005. Breast Diseases: A Year Book Quarterly 17:74-75, 2006. | |
| 13. | Hwang RF. Commentary on: The effect of sentinel node tumor burden on nonsentinel node status and recurrence rates in breast cancer. Ann Surg Oncol 12:705-711, 2005. Breast Diseases: A Year Book Quarterly 17:171, 2006. | |
| 14. | Hwang RF. Commentary on: The impact of nonvisualization of sentinel nodes of lymphoscintigraphy in breast cancer. Ann Surg Oncol 7:1-6, 2005. Breast Diseases: A Year Book Quarterly 17:79, 2006. | |
| 15. | Hwang R, Varner J. The role of integrins in tumor angiogenesis. Hematol Oncol Clin North Am 18(5):991-1006, 10/2004. PMID: 15474331. | |
| 16. | Hwang R. Commentary on: Extracapsular extension of the sentinel lymph node metastasis: a predictor of nonsentinel node tumor burden. Ann Surg 2003; 237: 607-613. Breast Diseases: A Year Book Quarterly 15:66-67, 2004. | |
| 17. | Hwang RF, Hunt K. Experimental approaches to soft tissue sarcoma. Surgical Oncology Clinics of North America 12(2):499-521, 2003. PMID: 12916466. | |
Abstracts | ||
| 1. | FitzSullivan E, Lari SA, Smith B, Caudel AS, Krishnamurthy S, Lucci A, Mittendorf EA, Babiera G, Black S, Wagner JL, Bedrosian I, Woodward W, Gainer SM, Hwang RF, Meric-Bernstam F, Hunt K, Kuerer HM. Incidence and consequence of close margins for ductal carcinoma in situ treated with mastectomy. Oral Presentation, 66th Annual Society of Surgical Oncology (SSO) Cancer Symposium, National Harbor, MD, Ann Surg Oncol 20(1 Suppl):S9 (#11), 2013. | |
| 2. | Yi M, Mittendorf EA, Hwang RF, Babiera GV, Kuerer HM, Crow J, Lange R, Shah R, Hunt K. Are mastectomy rates really increasing? Experiences from a single institution and a population-based database. Poster Presentation, American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago, IL (#1028), 2012. | |
| 3. | Hwang RF. Blocking tumor-stromal interactions in pancreatic cancer by targeting stromal cell-derived Dickkopf-3 (DKK3). Poster Presentation, 7th Annual Academic Surgical Congress, Las Vegas, NV, 2012. | |
| 4. | Hwang RF, Moore T, Mertens Hattersley M, Scarpitti M, Yang B, Devereaux E, Ramachandran V, Arumugam T, Ji B, Logsdon CD, Brown JL, Godin R. Hedgehog signaling in pancreatic cancer is dependent on stellate cells in a paracrine fashion, Oral Presentation, American Pancreatic Association (APA)/International Association of Pancreatology (IAP) Joint Annual Meeting, Miami, FL. Pancreas 41(8):1368 (#12076), 2012. | |
| 5. | Arumugam T, Fujii T, Haojie H, Hwang RF, Ramachandran V, Logsdon CD. Interleukin-8 (IL-8) expression is a surrogate marker for effects of gemcitabine on pancreatic ductal adenocarcinoma (PDAC) cells, American Pancreatic Association (APA)/International Association of Pancreatology Annual Meeting, Miami, FL. Pancreas 41(8):1347, 2012. | |
| 6. | Akay C, Whitsell T, Albarracin C, Hunt KK, Bassett R, Mittendorf EA, Yi M, Sahin A, Krishnamurthy, Kuerer H, Meric-Bernstam F, Babiera GV, Bedrosian I, Hwang RF. Intraoperative sentinel lymph node evaluation is accurate after neoadjuvant therapy for breast cancer. Poster Presentation, 65th Annual Cancer Symposium Society of Surgical Oncology (SSO), Orlando, FL. Ann Surg Oncol 19(Suppl 1):S86 (#P134), 2012. | |
| 7. | Allen LR, Gadgil PV, Bassett Jr. R, Hunt K, Mittendorf EA, Yi M, Babiera G, Kuerer HM, Ross MI, Bedrosian I, Meric-Bernstam F, Hwang RF. Nomogram to predict sentinel lymph node involvement in patients with clinically node-negative breast cancer receiving neoadjuvant chemotherapy. Poster Discussion Session, American Society of Clinical Oncology (ASCO) Breast Cancer Symposium, San Francisco, CA. J Clin Oncol 30(27 Suppl):150 (#103159), 2012. | |
| 8. | Charo C, Holla V, Arumugam T, Hwang RF, Yang P, Dubois RN, Menter DG, Logsdon CD, Ramachandran V. PGE2 regulats pancreatic stellate cell activity via the EP4 receptor, American Pancreatic Association (APA)/International Association of Pancreatology (IAP) Joint Annual Meeting, Miami, FL. Pancreas 41(8):1352, 2012. | |
| 9. | Veerapong J, Boughey J, Mittendorf E, Harrell R, Bassett R, Ross M, Yi M, Meric-Bernstam F, Babiera G, Kuerer H, Lucci A, Bedrosian I, Brodt J, Jakub J, Hunt K, Hwang R. A validated risk assessment of sentinel lymph node involvement in breast cancer patients. Poster Presentation, 64th Annual Society of Surgical Oncology Cancer Symposium (SSO), San Antonio, TX. Ann Surg Oncol 18(Suppl 1):S59, 2011. | |
| 10. | Hwang RF, Rivera A, Husted H, Moore T, Ramachandran V, Arumugam T, Ji B, Logsdon CD. Targeting periostin in the tumor-associated stroma of pancreatic cancer. Oral Presentation, 5th Annual Academic Surgical Congress (ASC), San Antonio, TX, 2010. | |
| 11. | Hwang RF, Moore T, Rivera A, Evans DB, Logsdon CB. Expression profile of pancreatic cancer-associated fibroblasts is distinct from carcinoma cells. Oral Presentation, 62nd. Annual Society of Surgical Oncology Cancer Symposium (SSO), Phoenix, AZ, 2009. | |
| 12. | Hwang RF, Evans DB, Coombes K, Logsdon CD. Gene expression profiling of pancreatic adenocarcinoma after neoadjuvant chemoradiation identifies potential markers of outcome. Poster Presentation, The American Association for Cancer Research (AACR), Denver, CO (#09-AB-7944), 2009. | |
| 13. | Hwang RF, Moore T, Ramachandran V, Arumugam R, Rivera A, Logsdon CD. Pancreatic cancer-associated fibroblasts promote angiogenesis in vitro and in vivo. Oral Presentation, Gastrointestinal Cancers Symposium, San Francisco, CA, 2009. | |
| 14. | Husted H, Moore T, Ji B, Ramachandran V, Arumugam T, Logsdon CD, Hwang RF. Pancreatic stellate cells secrete the WNT inhibitor DKK3. Oral Presentation, 40th Anniversary Meeting of the American Pancreatic Association (APA) and Japan Pancreas Society, Honolulu, HI (#09265), 2009. | |
| 15. | Kong AL, Hunt KK, Warneke CL, Hwang RF, Meric-Bernstam F, Bedrosian I, Yi M, Ross MI, Babiera GV, Mittendorf EA. Sentinel node dissection (SLND) is technically feasible and accurate in older breast cancer patients. Poster Presentation, Ann Surg Oncol 16(12) (#101), 2009. | |
| 16. | Bose D, Tamm E, Liu J, Kesmodel S, Lee JH, Gomez H, Fleming J, Evans DB, Hwang R. Incidental cystic lesions of the pancrease: multidisciplinary management of 350 patients. Oral Presentation, 94th Annual Clinical Congress American College of Surgeons (ACS), San Francisco, CA, 2008. | |
| 17. | Yi M, Meric-Bernstam F, Middleton LP, Arun BK, Bedrosian I, Babiera G, Hwang RF, Feig BW, Kuerer HM, Lucci A, Ross MI, Hunt KK. Predictors of contralateral breast cancer in patients with unilateral breast cancer. Poster Presentation, American Society of Breast Surgeons (ASBS), New York City, NY, 2008. | |
| 18. | Kong AL, Hunt KK, Yi M, Weatherspoon K, Bedrosian I, Tereffe W, Hwang R, Ross MI, Buchholz TA, Meric-Bernstam F. The impact of IMC nodal drainage on primary breast cancer outcome. Poster Presentation, American Society of Clinical Oncology (ASCO), Chicago, IL, 2008. | |
| 19. | Rivera A, Moore T, Ramachandran V, Arumugam T, Logsdon CD, Hwang R. Tumor-associated pancreatic stellate cells stimulate angiogenesis in vitro and in an orthotopic model of pancreatic cancer. Oral Presentation, American Pancreatic Association (APA), Chicago, IL, 2008. | |
| 20. | Hwang RF. An integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancer, 2nd Annual Academic Surgical Congress, Oral Presentation, Phoenix, AZ, 2/2007. | |
| 21. | Katz MH, Wolff RA, Pisters PW, Sun CC, Evans DB, Varadhachary GR, Fleming JB, Hwang RF. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. Oral Presentation, Southern Surgical Association (SSA) Meeting, Hot Springs, VA, 2007. | |
| 22. | Hwang RF, Moore T, Amos KD, Arumugam T, Ramachandran V, Logsdon C. Effect of pancreatic tumor-associated stellate cells on pancreatic tumor growth, metastasis and angiogenesis. Poster Presentation, 98th Annual Meeting of the American Association for Cancer Research (AACR), Los Angeles, CA (#562), 2007. | |
| 23. | Yi M, Hunt KK, Meric-Bernstam F, Bedrosian I, Hwang R, Kuerer HM, Lucci A, Ross MI, Akins J, Babiera GV. Sentinel lymph node biopsy in patients with multicentric invasive breast cancer. Poster Presentation, American Society of Clinical Oncology (ASCO) Breast Meeting, San Francisco, CA, 2007. | |
| 24. | Arumugam T, Hwang R, Moore T, Wang H, Brandt W, Westley B, Logsdon C. TFF1 is over expressed early in pancreatic cancer in response to cancer-stromal interactions and stimulates cancer cell invasiveness. Poster Presentation, 98th Annual Meeting of the American Association for Cancer Research (AACR), Los Angeles, CA (#2794), 2007. | |
| 25. | Arumugam T, Hwang RF, Moore TT, Wang H, Brandt W, Westley BR, Logsdon C. TFF1 is overexpressed early in pancreatic cancer and stimulates cancer cell invasion and stromal cell growth and migration. Oral Presentation, International Society of Gastrointestinal Oncology, Philadelphia, PA, 2007. | |
| 26. | Rosenkranz KM, Hartman K, Ghonimi E, Kuerer HM, Singletary SE, Hunt KK, Meric-Bernstam F, Lucci A, Hwang RF, Feig B, Ross MI, Ames F, Babiera GV. Breast cancer in the very elderly: treatment patterns in a comprehensive cancer center, American Society of Breast Surgeons, Poster Presentation, Baltimore, MD, 4/2006. | |
| 27. | Killary AM, Frazier M, Lott S, Carter J, Stivers D, Chen J, Hwang RF, Abbruzzese J, Sens S. A functional genomic approach to biomarker discovery in pancreatic cancer, Presented as a Poster, NCI, Early Detection Research Network Steering Committee Meeting, Philadelphia, PA, 3/2006. | |
| 28. | Yi M, Meric-Bernstam F, Akins JS, Hwang RF, Lucci A, Babiera GV, Hunt KK. How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer?, 29th Annual San Antonio Breast Cancer Symposium, Poster Presentation, (Abstract # 2013). Breast Cancer Res Treat 100:S84, 2006. | |
| 29. | Amos KD, Moore T, Arumugam T, Logsdon CD, Hwang RF. Pancreatic stellate cells promote malignant potential in pancreatic cancer, In: Proceedings of the 97th Annual Meeting of the American Association for Cancer Research; 2006 Apr 1-5; Washington, DC: AACR: Abstract 1679, 2006. | |
| 30. | Tereffe W, Buchholz TA, Oh JL, Perkins GH, Strom EA, Woodward WA, Yu TK, Hunt KK, Hwang RF. Radiotherapy targeting of regional nodes in sentinel lymph node-positive breast cancer patients who do not undergo axillary dissection, 29th Annual San Antonio Breast Cancer Symposium, Oral Presentation, (Abstract # 4086). Breast Cancer Res Treat 100:S200, 2006. | |
| 31. | Boughey JC, Khakpour N, Meric-Bernstam F, Ross MI, Hwang RF, Babiera GV. The routine use of sentinel lymph node surgery in prophylactic mastectomy is not warranted. Ann Surg Oncol 13:P64, 2006. | |
| 32. | Hwang R, Bucana C, Killion J, Evans D, Fidler IJ. Targeted therapy of human pancreatic cancer with STI571 (Gleevec) in an orthotopic nude mouse model. Ann Surg Onc 1:S23, 2003. | |
| 33. | Hwang R, Bucana C, Killion J, Evans DB, Fidler IJ. Targeted therapy of human pancreatic cancer with RPR127963E, a novel inhibitor of platelet-derived growth factor receptor, in an orthotopic nude mouse model. J Am Coll Surgeons 195:S7, 2002. | |
Book Chapters | ||
| 1. | Hwang RF. Stromal Barriers to Delivery. In: Mass Transport of Nanocarriers. Ed(s) Serda RE. Pan Stanford Publishing Pte. Ltd. Singapore, 83-95, 2013. ISBN: 978-981-4364-41-6. | |
| 2. | Fleming JB, Katz MHG, Hwang RF, Varadhachary GR. Pancreatic Cancer. In: 60 Years of Survival Outcomes at the University of Texas, M. D. Anderson Cancer Center. Ed(s) Rodriguez MA, Burke TW, Walters RS. Springer: New York, 119-132, 2012. | |
| 3. | Akay CL, Kuerer HM, Hwang RF. Sentinel Lymph Node Biopsy in Breast Cancer: The MD Anderson Cancer Center Approach. In: Advanced Therapy of Breast Disease, 3rd. Edition, 3rd. Edition. Ed(s) Babiera GV, Skoracki RJ, Esteva FJ. People's Medical Publishing House: Connecticut, USA, 545-555, 2012. | |
| 4. | Bowels TL, Amos KD, Hwang RF, Fleming JB. Small Bowel Malignancies and Carcinoid Tumors. In: The M.D. Anderson Surgical Oncology Handbook, 5th Ed. 5th Edition. Ed(s) Feig BW, Ching CD. Wolters Kluwer, Lippincott Williams & Wilkins: New York, 323-346, 2012. | |
| 5. | Kong A, Hwang RF. Sentinel Lymph Node Biopsy: An Overview. In: Breast Medical Techniques and Interdisciplinary Management. Ed(s) Dirbas F, Scott-Conner CEH. Springer: New York, 471-480, 2011. | |
| 6. | Logsdon C, Ji B, Hwang R. Novel Molecular Relationships Between Chronic Pancreatitis and Pancreatic Cancer. In: Handbook of Pancreatic Cancer. Ed(s) Neoptolemos J, Abbruzzese J, Buchler M, Urrutia R. Springer: New York, 285-315, 2009. ISBN: 978-0-387-77497-8. | |
| 7. | Hwang RF, Ross MI. Treatment Options and Surgical Techniques for Early-Stage Breast Cancer. In: Advanced Therapy in Surgical Oncology, 1. Ed(s) Pollock R, Curley S, Ross MI, Perrier ND. B.C. Decker: Hamilton, Ontario, 489-501, 2007. | |
| 8. | Hwang RF, Grau AM, Spitz FR, Bouvet M, Fuhrman GM, Berger DH. Pancreatic Adenocarcinoma. In: The M. D. Anderson Surgical Oncology Handbook. Lippincott Williams and Wilkins: Philadelphia, PA, 367-390, 2006. | |
| 9. | Amos KD, Hwang RF. Small-Bowel Malignancies and Carcinoid Tumors. In: The M. D. Anderson Surgical Oncology Handbook. Lippincott Williams and Wilkins: Philadelphia, PA, 241-260, 2006. | |
| 10. | Hwang R, Roseman B. Metastatic Cancer of Unknown Primary Site. In: The M.D. Anderson Surgical Oncology Handbook. Lippincott Williams and Wilkins, 409-424, 2002. | |
| 11. | Hwang R, Baril N, McGarvey M, Chiang M, Formenti S, Skinner K. Principles of Molecular Biology for Cancer Surgeons. In: Surgical Oncology: Multidisciplinary Approach to Difficult Problems. Oxford University Press, 1-43, 2002. | |
| 12. | Hwang R, Robinson E, Cusack J, Tyler D. Small Bowel Malignancies and Carcinoid Tumors. In: The M.D. Anderson Surgical Oncology Handbook. Lippincott Williams and Wilkins, 193-214, 2002. | |
Manuals, Teaching Aids, Other Teaching Publications | ||
| 1. | Hwang RF, Oates S. Skin-Sparing Mastectomy with Immediate Free-TRAM Reconstruction; Video Clip for "Kuerer's Breast Surgical Oncology". McGraw-Hill Professional: New York, NY, Video 11, 2010. | |
Other | ||
| 1. | Online Reference Publications. Hwang, RF. Tumor-stromal interactions assessed by co-injection of pancreatic stellate and cancer cells. The Pancreapedia Exocrine Pancreas Knowledge Base , http://www.pancreapedia.org/about/our-name, University of Michigan, 2011 . | |
Last updated: 3/18/2013
- Global Navigation
- About Us
- Locations
- Calendar
- Careers
- Publications
- How You Can Help
- Contact Us
- Newsroom
- Site Index
- Patient and Cancer Information
- myMDAnderson
- Cancer Information
- Patient Information
- Care Centers & Clinics
- Children's Cancer Hospital
- Services & Amenities
- Education and Research
- Departments, Programs and Labs
- PeopleFinder
- Research at MD Anderson
- Education & Training
- Resources for Professionals
- For Employees
- Employee Alert Information
- Employee Resources
- Doing Business
- Vendors & Suppliers
- Partners & Affiliates
- Legal and Policy
- Legal Statements
- Site Policies
- Reporting Fraud, Waste & Abuse
© 2010 The University of Texas M. D. Anderson Cancer Center

